FAK inhibitor-mediated reversal of HDAC inhibitor-mediated breast cancer metastasis suggests the combinatorial therapeutic opportunities of FAK and HDAC inhibitors in breast cancer. The gene discussed is HDAC9; the disease is breast cancer.